Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
600351.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.00
vs 0.05
Q1.23
+50%
0.14
vs 0.09
Q2.23
+112%
0.08
vs 0.04
Q3.23
+415%
0.06
vs 0.01
Q4.23
N/A
-0.02
vs -0.00
Q1.24
+7%
0.15
vs 0.14
Q2.24
+18%
0.09
vs 0.08
Q3.24
+27%
0.08
vs 0.06
Q4.24
+157%
0.01
vs -0.02
Q1.25
-100%
NA
vs 0.15
Sales Growth
YoY
Current
Estimates
Q4.22
+34%
745.4M vs 558.3M
Q1.23
+15%
800.5M vs 694.3M
Q2.23
+22%
732.3M vs 599.6M
Q3.23
-2%
666.6M vs 678.8M
Q4.23
-5%
710.3M vs 745.4M
Q1.24
-5%
761.2M vs 800.5M
Q2.24
-9%
664.1M vs 732.3M
Q3.24
+2%
677.8M vs 666.6M
Q4.24
-21%
564.5M vs 710.3M
Q1.25
-19%
614.5M vs 761.2M
Return on Equity
QoQ
Q2.23
+2%
0.02
vs 0.03
Q3.23
+2%
0.02
vs 0.02
Q4.23
0%
-0.00
vs 0.02
Q1.24
+4%
0.04
vs -0.00
Q2.24
+2%
0.02
vs 0.04
Q3.24
+2%
0.02
vs 0.02
Q4.24
+0%
0
vs 0.02
Q1.25
+4%
0.04
vs 0
Institutionnal Ownership
Relative Strength
600351.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao brands. It also offers plastic bottles and cartons. The company provides its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.
SHH
-0.01Â ( -0.16%)
Relative Strenght
Volume Buzz
-18%
Earning Acce
No
Dist 52w H.
10%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 600351.SS compares to sector?